TSXV - Delayed Quote CAD
Nova Leap Health Corp. (NLH.V)
0.2450
0.0000
(0.00%)
At close: April 24 at 9:51:09 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
25,760.6060
25,760.6060
26,179.0250
28,205.1040
21,279.0830
Cost of Revenue
15,873.6780
15,873.6780
16,410.6470
18,229.6360
14,067.9400
Gross Profit
9,886.9280
9,886.9280
9,768.3780
9,975.4680
7,211.1430
Operating Expense
9,023.2160
9,023.2160
9,308.2260
11,037.5780
3,291.4940
Operating Income
863.7120
863.7120
460.1520
-1,062.1100
3,919.6490
Net Non Operating Interest Income Expense
-106.8560
-106.8560
-144.7480
-270.9940
-401.1220
Other Income Expense
1,055.1540
1,055.1540
-1,681.3980
126.5430
-1,045.2930
Pretax Income
1,812.0100
1,812.0100
-1,365.9940
-1,206.5610
2,473.2340
Tax Provision
433.5420
433.5420
-311.3130
-370.8160
712.5210
Net Income Common Stockholders
1,378.4680
1,378.4680
-1,054.6810
-835.7450
1,760.7130
Diluted NI Available to Com Stockholders
1,378.4680
1,378.4680
-1,054.6810
-835.7450
1,760.7130
Basic EPS
0.02
--
-0.01
-0.01
0.02
Diluted EPS
0.02
--
-0.01
-0.01
0.02
Basic Average Shares
86,245.4820
--
86,209.2520
81,458.7700
74,404.3950
Diluted Average Shares
86,794.9230
--
86,209.2520
81,458.7700
77,653.8160
Total Operating Income as Reported
863.7120
863.7120
460.1520
-1,062.1100
-1,231.3800
Total Expenses
24,896.8940
24,896.8940
25,718.8730
29,267.2140
17,359.4340
Net Income from Continuing & Discontinued Operation
1,378.4680
1,378.4680
-1,054.6810
-835.7450
1,760.7130
Normalized Income
556.3731
556.3731
227.0400
-949.3140
2,486.4682
Interest Expense
106.8560
106.8560
144.7480
270.9940
401.1220
Net Interest Income
-106.8560
-106.8560
-144.7480
-270.9940
-401.1220
EBIT
1,918.8660
1,918.8660
-1,221.2460
-935.5670
2,874.3560
EBITDA
2,502.5610
2,502.5610
-336.1350
420.3530
3,735.8200
Reconciled Cost of Revenue
15,873.6780
15,873.6780
16,410.6470
18,229.6360
14,067.9400
Reconciled Depreciation
583.6950
583.6950
885.1110
1,355.9200
861.4640
Net Income from Continuing Operation Net Minority Interest
1,378.4680
1,378.4680
-1,054.6810
-835.7450
1,760.7130
Total Unusual Items Excluding Goodwill
1,080.6520
1,080.6520
-1,660.0500
163.9590
-1,019.4520
Total Unusual Items
1,080.6520
1,080.6520
-1,660.0500
163.9590
-1,019.4520
Normalized EBITDA
1,421.9090
1,421.9090
1,323.9150
256.3940
4,755.2720
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
258.5571
258.5571
-378.3290
50.3900
-293.6968
12/31/2021 - 11/7/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NPTH.V NeuPath Health Inc.
0.2000
+5.26%
JYNT The Joint Corp.
10.01
+1.32%
DR.TO Medical Facilities Corporation
14.55
-1.76%
PIII P3 Health Partners Inc.
8.99
+2.74%
HCSG Healthcare Services Group, Inc.
14.21
+1.28%
CHE Chemed Corporation
581.51
+1.14%
AIDX.TO Healwell AI Inc.
1.4800
-1.33%
WELL.TO WELL Health Technologies Corp.
3.9600
-0.50%